Back to all articles

EQT Wins Mandate to Run Europe's €5B Scaleup Fund, Beating Atomico in Brussels' Biggest Tech Bet

Michael Schneider
8 min read
EQT Wins Mandate to Run Europe's €5B Scaleup Fund, Beating Atomico in Brussels' Biggest Tech Bet

TL;DR

The European Commission has handed EQT the mandate to run the €5 billion Scaleup Europe Fund, the largest pan-European late-stage tech vehicle ever assembled. Roughly €2.5 billion is already committed, split between €1 billion from the European Innovation Council and €1.5 billion from heavyweight LPs including Novo Holdings, Allianz, APG, CriteriaCaixa, Santander, the Wallenberg family, and EQT itself. The fund will write Series B and beyond cheques into AI, quantum, clean energy, space, biotech, and dual-use companies, with first investments expected in autumn 2026. EQT beat Atomico in the final round, with Eurazeo, Northzone, and Vitruvian eliminated earlier. This is the EU's most concrete attempt yet to stop foreign capital from acquiring its best technology before it can scale.

Key Takeaways

Brussels picked a commercial GP, not a state vehicle. The optics of selecting EQT, a publicly listed €269 billion private markets house, over Atomico (a pure VC) signal that the Commission wants returns alongside strategic outcomes. A state-run fund would have been the easier political choice. Choosing a commercial manager is a bet that discipline matters more than control.

The LP stack is unusually credible for a Brussels-led vehicle. Novo Holdings, APG (the manager behind Dutch pension giant ABP), Allianz, CriteriaCaixa, Santander, and the Wallenberg family rarely show up together in a single fund. Their participation is the closest thing Europe has to a "European Sequoia LP base" and validates the thesis that scaling capital is the actual missing layer, not seed money.

The mandate is wider than it looks. AI, quantum, space, biotech, clean energy, and dual-use is a lot of ground for one fund, even at €5 billion. EQT will need to staff aggressively, lean on its existing Ventures and infrastructure teams, and probably syndicate hard. The risk is that the fund becomes a follow-on machine for hot rounds rather than a thesis-driven late-stage shop.

The fund's real test is geopolitical, not financial. DeepMind sold to Google for £400 million. ARM went to SoftBank for £24 billion. Roughly $24 billion of European spinout value has been captured by US acquirers since 2019. If EQT cannot meaningfully change that exit pattern, the Scaleup Europe Fund becomes an expensive consolation prize.

Fund Overview

Fund Name: Scaleup Europe Fund
Fund Size: €5 billion target (≈ €2.5 billion committed at announcement)
Stage: Series B and beyond (late-stage growth)
Check Size: Not disclosed; expected to write growth-stage tickets in the €50 to €300 million range based on portfolio scale
Geography: European Union, with mandate to back companies that maintain European roots while scaling globally
Focus: Artificial intelligence, quantum computing, clean energy, space technology, biotech and medical innovation, dual-use technologies
Key LPs: European Innovation Council (€1 billion), Novo Holdings, Allianz, APG Asset Management, CriteriaCaixa, Santander (via Mouro Capital), Wallenberg family vehicles, European foundations, EQT

Why This Fund Matters

Europe's structural problem in technology is not innovation. It is what happens once a company crosses the Series B line and needs hundreds of millions to compete with US and Chinese counterparts. The continent has consistently produced category-defining research and category-defining founders, then watched the resulting companies either stall for lack of growth capital or get bought out by foreign acquirers at prices that later look embarrassing. The Scaleup Europe Fund is the EU's first credible attempt to close that gap at a size that actually matters.

The geopolitical context makes the case even stronger. Chinese capital flowed roughly $10 billion into the EU and UK in 2024, about 50 percent higher than the prior year, and forced multiple European governments to block or unwind acquisitions of sensitive semiconductor assets. The US has not waited politely either: Microsoft acquired SwiftKey, PayPal swallowed iZettle for $2.2 billion, and the long list of strategic European technology now sitting inside US balance sheets keeps growing. €5 billion of patient European capital is not enough to reverse those flows on its own, but it raises the price tag of every foreign take-out and gives founders a domestic option they did not have before.

What is genuinely new here is that the EU has finally accepted that scaling capital is a market problem, not a grant problem. Previous attempts to "fix" European venture leaned on subsidies, tax incentives, or government-backed funds-of-funds. Scaleup Europe Fund inverts the logic. It hires a commercial GP, gives them institutional LP money alongside public money, and sets a return expectation. If that structure works, it becomes a template the Commission can repeat in adjacent strategic sectors.

The skeptical read is that public-private vehicles of this kind almost always discover tension between commercial discipline and political pressure to back "European champions." That tension is real and EQT will face it. The fund's credibility will be determined by what it passes on, not what it funds.

The Team

EQT, headquartered in Stockholm, manages €269 billion across private equity, infrastructure, real estate, and venture capital. The firm's early-stage arm, EQT Ventures, has backed more than 140 founding teams from offices in London, Stockholm, Berlin, Paris, Amsterdam, and San Francisco, with portfolio companies including Epidemic Sound, Sana Labs, humanoid robotics firm 1X, Bespak, and diagnostics firm Binx Health.

Per Franzén, EQT's CEO and Managing Partner, is leading the firm's overall commitment to the mandate. Ted Persson and Victor Englesson, both Partners at EQT, have been proposed as Co-Heads of the Scaleup Europe Fund Advisory Team. Persson brings consumer and SaaS deal experience from EQT Ventures; Englesson has spent years bridging the firm's growth and venture arms. The structure puts late-stage discipline on top, with venture-trained partners running the deal flow.

What This Means for Founders

If you are running a European Series B-and-beyond company in AI, quantum, dual-use, space, clean energy, or biotech, the Scaleup Europe Fund will become a default cheque in your next round. The fund is too large to ignore and too politically prominent to move slowly. Expect aggressive outreach in the second half of 2026 and into 2027, particularly to companies that have raised crossover rounds from US-led syndicates.

The strategic value-add for founders goes beyond money. Pitching this fund successfully creates a public-private signaling effect that helps with regulators, with sovereign customers, and with future strategic acquirers who do not want to fight the Commission on antitrust grounds. That is not a small thing for any company building dual-use, defense, or critical-infrastructure technology.

Fund Momentum Take

This is the most important European venture story of 2026, and it is not even close. The Scaleup Europe Fund is the first piece of EU industrial policy that actually behaves like a fund, with a real GP, real LPs, real return expectations, and real selection pressure on portfolio companies. If it works, the structure becomes a blueprint for how Brussels participates in markets without distorting them. If it fails, it will fail loudly, and the political appetite to try again will be limited.

Our bet is that EQT will deliver respectable but not transformational returns, somewhere in the 2 to 3x net range over the life of the fund, while moving the needle materially on European late-stage participation in marquee deals. The bigger upside is the demonstration effect. If APG, Novo, Allianz, CriteriaCaixa, and the Wallenberg family see this work, they will deploy more European capital into European tech as a category, and that flywheel matters far more than any single fund's IRR.

The risk worth watching is political drift. The Commission has every incentive to lean on EQT to back companies in struggling member states, in defense-aligned sectors, or in projects with high symbolic value but weak unit economics. EQT will need to push back, and the first time it does so publicly will tell us whether this fund is a real GP or a polite extension of policy.

Frequently Asked Questions

How big is the Scaleup Europe Fund and how much is committed?
The fund targets €5 billion in total commitments. Approximately €2.5 billion was already committed at announcement, split between €1 billion from the European Innovation Council and €1.5 billion from private LPs including Novo Holdings, Allianz, APG, CriteriaCaixa, Santander, and Sweden's Wallenberg family.

What stage and sectors will the fund invest in?
Series B and later, with check sizes appropriate for late-stage growth rounds. Target sectors include artificial intelligence, quantum computing, clean energy, space technology, biotech and medical innovation, and dual-use technologies relevant to European strategic autonomy.

When will the fund start deploying capital?
First investments are expected in autumn 2026. The fund will be formally presented at the EIC Summit on 3 June 2026, after which final documentation and structuring complete.

Why did EQT win the mandate?
EQT beat Atomico in the final round, with Eurazeo, Northzone, and Vitruvian Partners eliminated at earlier stages. The Commission appears to have valued EQT's scale, multi-asset experience, and the breadth of institutional LP relationships the firm could bring alongside the EIC's anchor commitment.

Does this replace EQT Ventures or other EQT funds?
No. The Scaleup Europe Fund is a separate vehicle managed alongside EQT Ventures and EQT's other strategies. EQT is also committing its own balance sheet capital into the fund, which aligns incentives with external LPs.


Have a fund closing to announce? Submit your fund here.

Need help raising capital? Check out our Fundraising Advisory services.

Share